YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research
YD Bio Limited, a Nasdaq-listed biopharmaceutical company, highlighted a new peer-reviewed study published in Bioengineering. Collaborating with Taipei Medical University researchers, YD Bio developed a data-driven computational framework, the Cargo Prioritization Score (CPS), to identify molecular candidates for potential stem-cell-based therapies…